Clinical & Payment Policies
Clinical Policies
Clinical policies are one set of guidelines used to assist in administering health plan benefits, either by prior authorization or payment rules. They include but are not limited to policies relating to evolving medical technologies and procedures, as well as pharmacy policies. Clinical policies help identify whether services are medically necessary based on information found in generally accepted standards of medical practice; peer-reviewed medical literature; government agency/program approval status; evidence-based guidelines and positions of leading national health professional organizations; views of physicians practicing in relevant clinical areas affected by the policy; and other available clinical information.
All policies found in the MHS Clinical Policy Manual apply to MHS members. Policies in the MHS Clinical Policy Manual may have either a MHS or a “Centene” heading. MHS utilizes InterQual criteria for those medical technologies, procedures or pharmaceutical treatments for which a MHS clinical policy does not exist. InterQual is a nationally recognized evidence-based decision support tool. In addition, MHS may from time to time delegate utilization management of specific services; in such circumstances, the delegated vendor’s guidelines may also be used to support medical necessity and other coverage determinations. Other non-clinical policies (e.g., payment policies) or contract terms may further determine whether a technology, procedure or treatment that is not addressed in the Clinical Policy Manuals or InterQual criteria is payable by MHS.
If you have any questions regarding these policies, please contact Member Services and ask to be directed to the Medical Management department.
Ambetter Clinical Policies
For Ambetter information, please visit our Ambetter website.
Ambetter Pharmacy Policies
For Ambetter information, please visit our Ambetter website.
Medicaid Clinical Policies
- Adopted Clinical Practice and Preventive Health Guidelines (CPG Grid) (PDF)
- Air Ambulance (CP.MP.175) (PDF)
- Applied Behavioral Analysis Documentation Requirements (CP.BH.105) (PDF)
- Behavioral Health Treatment Documentation Requirements (CP.BH.500) (PDF)
- Biofeedback for Behavioral Health Disorders (CP.BH.300) (PDF)
- Burn Surgery (CP.MP.186) (PDF)
- Clinical Trials (CP.MP.94) (PDF)
- Concert Genetic Testing: Aortopathies and Connective Tissue Disorders (V1.2024) (PDF)
- Concert Genetic Testing: Cardiac Disorders (V1.2024) (PDF)
- Concert Genetic Testing: Dermatologic Conditions (V1.2024) (PDF)
- Concert Genetic Testing: Epilepsy, Neurodegenerative, and Neuromuscular Conditions (V1.2024) (PDF)
- Concert Genetic Testing: Exome and Genome Sequencing for the Diagnosis of Genetic Disorders (V1.2024) (PDF)
- Concert Genetic Testing: Eye Disorders (V1.2024) (PDF)
- Concert Genetic Testing: Gastroenterologic Disorders (non-cancerous) (V1.2024) (PDF)
- Concert Genetic Testing: General Approach to Genetic and Molecular Testing (V1.2024) (PDF)
- Concert Genetic Testing: Hearing Loss (V1.2024) (PDF)
- Concert Genetic Testing: Hematologic Conditions (non-cancerous) (V1.2024) (PDF)
- Concert Genetic Testing: Hereditary Cancer Susceptibility (V1.2024) (PDF)
- Concert Genetic Testing: Immune, Autoimmune, and Rheumatoid Disorders (V1.2024) (PDF)
- Concert Genetic Testing: Kidney Disorders (V1.2024 (PDF)
- Concert Genetic Testing: Lung Disorders (V1.2024) (PDF)
- Concert Genetic Testing: Metabolic, Endocrine, and Mitochondrial Disorders (V1.2024) (PDF)
- Concert Genetic Testing: Multisystem Inherited Disorders, Intellectual Disability, and Developmental Delay (V1.2024) (PDF)
- Concert Genetic Testing: Non-invasive Prenatal Screening (NIPS) (V1.2024) (PDF)
- Concert Genetic Testing: Pharmacogenetics (V1.2024) (PDF)
- Concert Genetic Testing: Preimplantation Genetic Testing (V1.2024) (PDF)
- Concert Genetic Testing: Prenatal and Preconception Carrier Screening (V1.2024) (PDF)
- Concert Genetic Testing: Prenatal Diagnosis (via Amniocentesis, CVS, or PUBS) and Pregnancy Loss (V1.2024) (PDF)
- Concert Genetic Testing: Skeletal Dysplasia and Rare Bone Disorders (V1.2024) (PDF)
- Concert Genetics Oncology: Algorithmic Testing (V1.2024) (PDF)
- Concert Genetics Oncology: Cancer Screening (V1.2024) (PDF)
- Concert Genetics Oncology: Circulating Tumor DNA and Circulating Tumor Cells (Liquid Biopsy) (V1.2024) (PDF)
- Concert Genetics Oncology: Cytogenetic Testing (V1.2024) (PDF)
- Concert Genetics Oncology: Molecular Analysis of Solid Tumors and Hematologic Malignancies (V1.2024) (PDF)
- Cosmetic and Reconstructive Procedures (CP.MP.31) (PDF)
- Deep Transcranial Magnetic Stimulation for the Treatment of Obsessive Compulsive Disorder (CP.BH.201) (PDF)
- Diaphragmatic/Phrenic Nerve Stimulation (CP.MP.203) (PDF)
- Durable Medical Equipment and Orthotics and Prosthetics Guidelines (CP.MP.107) (PDF)
- Enteral and Formula Authorization Request (IN.CP.DME.03) (PDF)
- Experimental Technologies (CP.MP.36) (PDF)
- Fecal Incontinenece Treatments (CP.MP.137) (PDF)
- Fetal Surgery in Utero for Prenatally Diagnosed Malformations (CP.MP.129) (PDF)
- Hospice Services (CP.MP.54) (PDF)
- Implantable Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea (CP.MP.180) (PDF)
- Implantable Intrathecal or Epidural Pain Pump (CP.MP.173) (PDF)
- Intensity-Modulated Radiotherapy (CP.MP.69) (PDF)
- IV Moderate Sedation, IV Deep Sedation, and General Anesthesia for Dental Procedures (CP.MP.61) (PDF)
- Lysis of Epidural Lesions (CP.MP.116) (PDF)
- Mechanical Stretching Devices for Joint Stiffness and Contracture (CP.MP.144) (PDF)
- Osteogenic Stimulation (CP.MP.194) (PDF)
- Pediatric Oral Function Therapy (CP.MP.188) (PDF)
- Posterior Tibial Nerve Stimulation for Voiding Dysfunction (CP.MP.133) (PDF)
Medicaid Pharmacy Policies
For Medicaid information, please visit our Medicaid Preferred Drug Lists.
Medicare Clinical Policies
For Medicare information, please visit our Medicare Prior Authorization website.
Payment Policies
Health care claims payment policies are guidelines used to assist in administering payment rules based on generally accepted principles of correct coding. They are used to help identify whether health care services are correctly coded for reimbursement. Each payment rule is sourced by a generally accepted coding principle. They include, but are not limited to claims processing guidelines referenced by the Centers for Medicare and Medicaid Services (CMS), Publication 100-04, Claims Processing Manual for physicians/non-physician practitioners, the CMS National Correct Coding Initiative policy manual (procedure-to-procedure coding combination edits and medically unlikely edits), Current Procedural Technology guidance published by the American Medical Association (AMA) for reporting medical procedures and services, health plan clinical policies based on the appropriateness of health care and medical necessity, and at times state-specific claims reimbursement guidance.
All policies found in the MHS Payment Policy Manual apply with respect to MHS members. Policies in the MHS Payment Policy Manual may have either a MHS or a “Centene” heading. In addition, MHS may from time to time employ a vendor that applies payment policies to specific services; in such circumstances, the vendor’s guidelines may also be used to determine whether a service has been correctly coded. Other policies (e.g., clinical policies) or contract terms may further determine whether a technology, procedure or treatment that is not addressed in the Payment Policy Manual is payable by MHS.
If you have any questions regarding these policies, please contact Member Services and ask to be directed to the Medical Management department.
Ambetter Payment Policies
For Ambetter information, please visit our Ambetter website.
Medicaid Payment Policies
- 3-Day Payment Window (CC.PP.500) (PDF)
- Add on Code Billed Without Primary Code (CC.PP.030) (PDF)
- Assistant Surgeon (CC.PP.029) (PDF)
- Bilateral Procedures (CC.PP.037) (PDF)
- Cerumen Removal (CC.PP.008) (PDF)
- Clean Claims (CC.PP.021) (PDF)
- Code Editing Overview (CC.PP.011) (PDF)
- Cosmetic Procedures (CC.PP.024) (PDF)
- Distinct Procedural Modifiers: XE, XS, XP, & XU (CC.PP.020) (PDF)
- Duplicate Primary Code Billing (CC.PP.044) (PDF)
- E&M Bundling with Labs and Radiology (CC.PP.010) (PDF)
- E&M Medical Decision-Making (CC.PP.051) (PDF)
- Global Maternity Billing (CC.PP.016) (PDF)
- Hospital Visit Codes Billed with Labs (CC.PP.023) (PDF)
- Inpatient Only Procedures (CC.PP.018) (PDF)
- Intravenous Hydration (CC.PP.012) (PDF)
- Maximum Units (CC.PP.007) (PDF)
- Moderate Conscious Sedation (CC.PP.015) (PDF)
- Modifier DOS Validation (CC.PP.034) (PDF)
- Modifier to Procedure Code Validation (CC.PP.028) (PDF)
- Multiple CPT Code Replacement (CC.PP.033) (PDF)
- NCCI Unbundling (CC.PP.031) (PDF)
- Never Paid Events (CC.PP.017) (PDF)
- New Patient (CC.PP.036) (PDF)
- Not Medically Necessary Inpatient Services (CC.PP.060) (PDF)
- Outpatient Consultation (CC.PP.039) (PDF)
- Physician's Consultation Services (CC.PP.054) (PDF)
- Physician's Office Lab Testing (CC.PP.055) (PDF)
- Place of Service Mismatch (CC.PP.063) (PDF)
- Post-Operative Visits (CC.PP.042) (PDF)
- Pre-Operative Visits (CC.PP.041) (PDF)
- Professional Component (CC.PP.027) (PDF)
- Professional Services (Visit Codes) Billed With Labs (CC.PP.019) (PDF)
- Pulse Oximetry (CC.PP.025) (PDF)
- Status "B" Bundled Services (CC.PP.046) (PDF)
- Status P Bundled Services (CC.PP.049) (PDF)
- Supplies Billed on Same Day As Surgery (CC.PP.032) (PDF)
- Transgender Related Services (CC.PP.047) (PDF)
- Unbundled Professional Services (CC.PP.043) (PDF)
- Unbundled Surgical Procedures (CC.PP.045) (PDF)
- Unlisted Procedure Codes (CC.PP.009) (PDF)
- Urine Specimen Validity Testing (CC.PP.056) (PDF)
- Visits On Same Day As Surgery (CC.PP.040) (PDF)